财通资管中证1000指数增强A（019402）基金经理为辛晨晨。 1月12日，吉比特涨1.89%，截至发稿，报476.05元/股，成交13.60亿元，换手率4.00%，总市值342.95亿 元。吉比特股价已经连续3天上涨，区间累计涨幅6.55%。 资料显示，厦门吉比特网络技术股份有限公司位于福建省厦门软件园二期望海路4号101室，成立日期 2004年3月26日，上市日期2017年1月4日，公司主营业务涉及专业从事网络游戏创意策划、研发制作及 商业化运营。 从基金十大重仓股角度 数据显示，财通证券资管旗下1只基金重仓吉比特。财通资管中证1000指数增强A（019402）三季度持 有股数200股，占基金净值比例为0.91%，位居第四大重仓股。根据测算，今日浮盈赚取约1768元。连 续3天上涨期间浮盈赚取5850元。 财通资管中证1000指数增强A（019402）成立日期2024年4月29日，最新规模1143.64万。今年以来收益 6.15%，同类排名1663/5580；近一年收益38.23%，同类排名2054/4203；成立以来收益47.33%。 截至发稿，辛晨晨累计任职时间5年127天，现任基金资产总规模125 ...

Group 1 - The core viewpoint of the news is that Nocera Biopharma has seen a continuous increase in its stock price, reflecting positive market sentiment and potential investment opportunities [1] - As of January 12, Nocera Biopharma's stock price is 22.58 yuan per share, with a total market capitalization of 39.846 billion yuan and a trading volume of 2.12 billion yuan [1] - The company specializes in the research, production, and commercialization of biopharmaceuticals, focusing on unmet clinical needs in oncology and autoimmune diseases [1] Group 2 - Morgan Stanley's fund holds a significant position in Nocera Biopharma, with the Morgan Stanley Hong Kong-Shanghai Select Mixed A Fund owning 420,000 shares, representing 6.87% of the fund's net value [2] - The fund has generated a floating profit of approximately 69,720 yuan during the four-day stock price increase [2] - The Morgan Stanley Hong Kong-Shanghai Select Mixed A Fund has a total asset size of 67.3812 million yuan and has achieved a year-to-date return of 14.11% [2]

Group 1 - The core viewpoint of the news is that Kelun Pharmaceutical has experienced a continuous increase in stock price, rising for seven consecutive days with a cumulative increase of 17.86% [1] - As of the report, Kelun Pharmaceutical's stock price is 33.98 yuan per share, with a total market capitalization of 54.302 billion yuan and a trading volume of 876 million yuan [1] - The company's main business involves the development, production, and sales of large-volume infusion products, with revenue composition being 48.37% from non-infusion products, 41.28% from infusion products, 7.01% from research projects, and 3.33% from other sources [1] Group 2 - From the perspective of fund holdings, one fund under Shenwan Hongyuan has a significant position in Kelun Pharmaceutical, with a holding of 106,000 shares, representing 1.56% of the fund's net value [2] - The fund, Shenwan Hongyuan CSI Pharmaceutical Bio Index A, has seen a floating profit of approximately 54,620 yuan during the seven-day stock price increase [2] - The fund has a total asset size of 2.22 billion yuan, with a year-to-date return of 6.59% and a one-year return of 20.61% [2]

Group 1 - The core viewpoint of the news is that Beijing Chunzhen Technology Co., Ltd. has seen a stock price increase of 5.33%, reaching 243.69 CNY per share, with a total market capitalization of 49.534 billion CNY as of the report date [1] - The company, established on May 16, 2011, and listed on February 2, 2018, specializes in professional audio and video control equipment and solutions [1] - The revenue composition of the company includes professional audio-visual products (68.12%), virtual reality products (24.42%), supporting products (4.17%), professional chip products (2.01%), and others (1.29%) [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) is among the top ten circulating shareholders of Chunzhen Technology, having reduced its holdings by 18,700 shares to 1.2907 million shares, representing 0.63% of circulating shares [2] - The ETF has achieved a year-to-date return of 7.05%, ranking 1300 out of 5580 in its category, and a one-year return of 45.31%, ranking 1627 out of 4203 [2] - The fund manager, Cui Lei, has a tenure of 7 years and 68 days, with the fund's total asset size at 122.76 billion CNY and a best return of 234.52% during the tenure [3]

Group 1 - The core viewpoint of the news is that Xingye Technology's stock has seen a significant increase of 5.36%, reaching a price of 15.32 CNY per share, with a total market capitalization of 4.528 billion CNY [1] - Xingye Technology, established on December 14, 1992, and listed on May 7, 2012, specializes in the development, production, and sales of mid-to-high-end cowhide leather for shoe uppers [1] - The company's revenue composition includes leather for bags and belts at 63.62%, automotive interior leather at 28.47%, second-layer leather collagen product raw materials at 3.70%, other leather at 3.08%, and additional categories at 1.13% [1] Group 2 - Among the top circulating shareholders of Xingye Technology, Yongying Fund's advanced manufacturing mixed fund (018124) has entered the top ten, holding 14.4334 million shares, which is 4.93% of the circulating shares [2] - The Yongying Advanced Manufacturing Mixed Fund (018124) was established on May 4, 2023, with a current scale of 4.697 billion CNY, and has achieved a year-to-date return of 4.82% [2] - The fund has a one-year return of 93.84%, ranking 220 out of 8,157 in its category, and a cumulative return since inception of 163.04% [2]

科技引领（562380）成立日期2023年6月26日，最新规模1.06亿。今年以来收益9.64%，同类排名 573/5579；近一年收益40.22%，同类排名1915/4202；成立以来收益17.63%。 科技引领（562380）基金经理为王帅。 截至发稿，王帅累计任职时间6年201天，现任基金资产总规模289.44亿元，任职期间最佳基金回报 90.33%， 任职期间最差基金回报-31.79%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 1月12日，光迅科技涨5.36%，截至发稿，报76.06元/股，成交17.54亿元，换手率3.02%，总市值613.56 亿元。 资料显示，武汉光迅科技股份有限公司位于湖北省武汉市江夏区藏龙岛开发区潭湖路1号，成立日期 2001年1月22日，上市日期2009年8月21日，公司主营业务涉及光电子器件及子系统产品研发、生产、销 售及技术服务。主营业务收入构成为：数据与接入70.86%，传输28.94%，其他0.20%，其他(补 充)0. ...

Group 1 - The core viewpoint of the news is that Xian Xice Testing Technology Co., Ltd. has seen a significant increase in its stock price, rising 5.22% to 155.49 CNY per share, with a total market capitalization of 13.123 billion CNY and a cumulative increase of 11.91% over three days [1] - The company specializes in inspection and testing services for military equipment and civil aircraft products, with its main business revenue composition being: environmental and reliability testing (49.49%), electronic assembly business (29.38%), electromagnetic compatibility testing (10.81%), electronic component testing (8.18%), testing equipment sales (1.88%), and others (0.26%) [1] - The company was established on June 1, 2010, and went public on July 26, 2022, located in Xi'an High-tech Zone, Shaanxi Province [1] Group 2 - Longcheng Fund's Longcheng Jiujia Innovation Growth Mixed A Fund (004666) has entered the top ten circulating shareholders of Xice Testing, holding 1.2 million shares, which is 2.06% of the circulating shares, with a floating profit of approximately 9.264 million CNY today [2] - The fund has achieved a year-to-date return of 12.8% and a one-year return of 116.15%, ranking 221 out of 9012 and 69 out of 8157 respectively in its category [2] - The fund manager, You Guoliang, has a tenure of 6 years and 83 days, with the best fund return during his tenure being 274.22% [3]

Group 1 - The core viewpoint of the news is that Rihuan Technology has seen a stock price increase of 5.23%, reaching 73.66 yuan per share, with a total market capitalization of 12.198 billion yuan [1] - Rihuan Technology, established on July 22, 2009, is a leading supplier of industrial X-ray intelligent detection equipment in China, focusing on the research, production, sales, and service of micro-focus and high-power X-ray detection equipment [1] - The company's main business revenue composition includes: X-ray intelligent detection equipment (47.07%), integrated circuits and electronic manufacturing (24.31%), new energy battery detection (11.24%), castings and welds detection (10.58%), spare parts and others (5.81%), and other X-ray detection equipment (1.00%) [1] Group 2 - Among the top circulating shareholders of Rihuan Technology, a fund under the Fortune Fund, specifically the Fortune Tianyi Value Mixed A/B (100020), has entered the top ten circulating shareholders, holding 1.1952 million shares, which accounts for 1.12% of the circulating shares [2] - The Fortune Tianyi Value Mixed A/B fund has a total scale of 3.761 billion yuan, with a year-to-date return of 1.61% and a one-year return of 16.07% [2]

Group 1 - The core point of the news is that Lushin Venture Capital has seen a significant stock price increase of 10% on January 12, reaching 35.85 CNY per share, with a total market capitalization of 26.685 billion CNY and a cumulative increase of 46.41% over four consecutive days [1] - Lushin Venture Capital was established on November 20, 1993, and listed on December 25, 1996, with its main business involving venture capital and abrasive tools manufacturing [1] - The revenue composition of Lushin Venture Capital is as follows: abrasive tools account for 66.42%, investment management for 28.24%, and other businesses for 5.33% [1] Group 2 - From the perspective of the top ten circulating shareholders, Huaxia Fund holds a position in Lushin Venture Capital, specifically through the Huaxia CSI 1000 ETF, which reduced its holdings by 4,500 shares in the third quarter, now holding 1.6182 million shares, representing 0.22% of circulating shares [2] - The Huaxia CSI 1000 ETF has achieved a year-to-date return of 7.05% and a one-year return of 45.11%, ranking 1297 out of 5579 and 1637 out of 4202 in its category, respectively [2] - The fund manager of Huaxia CSI 1000 ETF, Zhao Zongting, has been in the position for 8 years and 273 days, with a total fund asset scale of 355.865 billion CNY and a best fund return of 122.22% during his tenure [2]

Group 1 - The core viewpoint of the news is that Yidian Tianxia's stock price has seen a significant increase, rising 14.82% on January 12, reaching 60.50 CNY per share, with a total market capitalization of 28.549 billion CNY [1] - Yidian Tianxia's stock has experienced a cumulative increase of 27.42% over the past three days, indicating strong market performance [1] - The company, established on April 6, 2005, specializes in performance advertising services, brand advertising services, and management of top media accounts, with performance advertising contributing 96.62% to its revenue [1] Group 2 - Among the top shareholders of Yidian Tianxia, the Southern Fund's Southern CSI 1000 ETF (512100) reduced its holdings by 30,400 shares in the third quarter, now holding 3.0207 million shares, which is 0.81% of the circulating shares [2] - The Southern CSI 1000 ETF has generated a floating profit of approximately 23.5915 million CNY today and 34.2545 million CNY during the three-day increase [2] - The Southern CSI 1000 ETF, established on September 29, 2016, has a current scale of 76.63 billion CNY and has achieved a year-to-date return of 7.05% [2]